--- title: "Brixadi: A New Treatment Option for Opioid Use Disorder | CARMAhealth" description: "Brixadi: A New Treatment Option for Opioid Use Disorder Opioid use disorder (OUD) is a chronic and potentially fatal condition that affects millions of…" canonical: https://carmahealth.com/blog/brixadi-a-new-treatment-option-for-opioid-use-disorder source: https://carmahealth.com/blog/brixadi-a-new-treatment-option-for-opioid-use-disorder mirror_of: carmahealth.com content_hash: sha256:51f18ebadf875f63f057b62ff89eb3d1261356042f508fd50fb04f083befc16d generated_at: 2026-07-08T23:20:17.555Z robots: noindex, follow --- Blog # Brixadi: A New Treatment Option for Opioid Use Disorder July 2, 2023 · CARMAhealth [All Articles](/blog) (image: Brixadi: A New Treatment Option for Opioid Use Disorder) Opioid use disorder (OUD) is a chronic and potentially fatal condition that affects millions of people in the US. OUD is characterized by the compulsive use of opioids, such as heroin, fentanyl, or prescription painkillers, despite harmful consequences, an inability to stop or cut down, and significant disruption in interpersonal, social, and occupational functioning. Physical dependence, withdrawal symptoms, cravings, and increased risk of overdose and death are all associated with OUD. Buprenorphine is a medication that treats OUD by reducing withdrawal symptoms and cravings and partially blocking the effects of other opioids. Buprenorphine is a partial opioid agonist, which means it activates the same receptors in the brain as opioids, but to a lesser degree. Buprenorphine can be taken orally for OUD as a sublingual (under the tongue or in the cheek) tablet or rapid dissolving film. Brixadi is a new buprenorphine product that was approved by the FDA (Food and Drug Administration) on May 23, 2023. Brixadi is an extended-release injection that can be given weekly or monthly by a health care provider. Brixadi is available in different doses and formulations, depending on the patient’s needs and preferences. Brixadi offers several benefits for people with OUD: - It provides a steady level of buprenorphine in the body, which may improve treatment adherence and outcomes. - It reduces the risk of diversion, misuse, or accidental exposure of buprenorphine to others. - It eliminates the need for daily oral dosing, which may be inconvenient or difficult for some patients. - It may lower the cost of treatment compared to other buprenorphine products. Brixadi should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support. If you have OUD and are interested in Brixadi, talk to your health care provider at CARMAhealth about whether it is right for you. Brixadi may help you achieve long-term recovery from OUD and improve your quality of life. #### CARMAHEALTH TESTIMONIAL > This place was great for me my life has changed an I feel great now. Thanks Carma! **Joey Castillo** > Dr. Powell is amazing, as well as the staff. I would highly recommend this place to anyone. **Kate Penshorn** > Excellent mental health professionals in Austin!!! They truly care about their patients by offering first-class services!! **David B. Hutts** #### OPENING HOURS
Week Days8:00 – 5:00
SaturdayClosed
SundayClosed
#### Austin: [512-212-4670](tel:512-212-4670) #### Florida: [754-800-6301](tel:754-800-6301) #### [OUR MISSION](#d425f70dd863dc28d) CARMAhealth adopts a collaborative model of care that blends primary care medicine and behavioral health. We adopt a pragmatic, risk informed approach to care. Our goal is to create a medical home through the life span for our patients, their family and our community. **Sources and further reading:** [https://www.aafp.org/pubs/afp/issues/2019/1001/p416.html](https://www.aafp.org/pubs/afp/issues/2019/1001/p416.html) [https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine](https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine) [https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder](https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder) ## Make An Appointment ### Contact our friendly and knowledgeable representatives to schedule your appointment and learn more about what we can do for you. [SCHEDULE APPOINTMENT](https://carmahealth.com/contact-us/) Keep Reading ## Related Articles [ (image: Ozempic: A Potential Anti-Addiction Drug?) July 25, 2023 ### Ozempic: A Potential Anti-Addiction Drug? Ozempic: A Potential Anti-Addiction Drug? Ozempic is a semaglutide medication originally developed to treat type 2 diabetes and obesity by… Learn more ](/blog/ozempic-a-potential-anti-addiction-drug)[ (image: Brixadi vs. Other OUD Medications) July 2, 2023 ### Brixadi vs. Other OUD Medications Brixadi vs. Other OUD Medications Brixadi is a new treatment option for people with opioid use disorder (OUD). It is an injectable form of… Learn more ](/blog/brixadi-vs-other-oud-medications)[ (image: Understanding Meth Addiction: A Growing Threat) May 8, 2019 ### Understanding Meth Addiction: A Growing Threat Understanding Meth Addiction: A Growing Threat Rampant and escalating fatality has steered the American addiction conversation toward opio… Learn more ](/blog/understanding-meth-addiction-a-growing-threat) Take the First Step ## Start Feeling Like Yourself Again Whether you're exploring treatment for the first time or looking for a new practitioner, our psychiatrists are here to listen. [Book an Appointment](/new-patients) [Call (512) 212-4670](tel:5122124670) Accepting new patients · 15+ insurance plans accepted · Telehealth available